Treatment Sequence After Initiating Biologic Therapy for Patients With Rheumatoid Arthritis in Korea: A Nationwide Retrospective Cohort Study-Reference-Cited by-同舟云学术

Treatment Sequence After Initiating Biologic Therapy for Patients With Rheumatoid Arthritis in Korea: A Nationwide Retrospective Cohort Study

Published:2022-08-30 Issue:1 Volume:30 Page:26-35
ISSN:2093-940X
Container-title:Journal of Rheumatic Diseases
language:en
Short-container-title:J Rheum Dis

Author:

Kim Min Jung¹^ORCID,Park Jun Won²^ORCID,Lee Sun-Kyung¹^ORCID,Jang Yumi¹^ORCID,Kim Soyoung³^ORCID,Stoelzel Matthias⁴^ORCID,Chua Jonathan Lumen⁵^ORCID,Shin Kichul¹^ORCID

Affiliation:

1. Division of Rheumatology, Department of Internal Medicine, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul, Korea

2. Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea

3. Astellas Pharma Singapore Pte. Ltd, Singapore, Singapore

4. Astellas Pharma Europe B.V., Leiden, The Netherlands

5. IQVIA Asia Pacific, Singapore, Singapore

Publisher

Korean College of Rheumatology

Subject

Rheumatology

Link

http://pdf.medrang.co.kr/JRD/2023/030/JRD030-01-26.pdf

Reference23 articles.

1. Cost of Illness and Quality of Life of Patients with Rheumatoid Arthritis in South Korea